Trial · NCT05660135
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The rate of change in LDL-C | at 24 weeks | The rate of change in LDL-C at 12 weeks from baseline |
| Primary | The amount of change in LDL-C | at 24 weeks | The amount of change in LDL-C at 24 weeks from baseline |
| Secondary | The rate of change in LDL-C | at 12 weeks | The rate of change in LDL-C at 12 weeks from baseline |
| Secondary | The amount of change in LDL-C | at 12 weeks | The amount of change in LDL-C at 12 weeks from baseline |
| Secondary | The rate of change in SBP(Systolic Blood Pressure) | 12 weeks | The rate of change in SBP(Systolic Blood Pressure) at 12 weeks from baseline |
| Secondary | The rate of change in SBP(Systolic Blood Pressure) | 24 weeks | The rate of change in SBP(Systolic Blood Pressure) at 24 weeks from baseline |
| Secondary | The amount of change in SBP(Systolic Blood Pressure) | 12 weeks | The amount of change in SBP(Systolic Blood Pressure) at 12 weeks from baseline |
| Secondary | The amount of change in SBP(Systolic Blood Pressure) | 24 weeks | The amount of change in SBP(Systolic Blood Pressure) at 24 weeks from baseline |
| Secondary | The rate of change in lipid variable(TC, HDL-C, non-HDL-C, TG) | 12 weeks | The rate of change in lipid variable(TC, HDL-C, non-HDL-C, TG) at 12 weeks from baseline |
| Secondary | The rate of change in lipid variable(TC, HDL-C, non-HDL-C, TG) | 24 weeks | The rate of change in lipid variable(TC, HDL-C, non-HDL-C, TG) at 24 weeks from baseline |
| Secondary | The amount of change in lipid variable(TC, HDL-C, non-HDL-C, TG) | 12 weeks | The amount of change in lipid variable(TC, HDL-C, non-HDL-C, TG) at 12 weeks from baseline |
| Secondary | The amount of change in lipid variable(TC, HDL-C, non-HDL-C, TG) | 24 weeks | The amount of change in lipid variable(TC, HDL-C, non-HDL-C, TG) at 24 weeks from baseline |
| Secondary | Percentage of subjects who reached LDL-C target | 12 weeks | Percentage of subjects who reached LDL-C target according to Korean Society of Lipid/Arteriosclerosis's risk classification in the guidelines for the treatment of dyslipidemia (2018) at 12 weeks from baseline |
| Secondary | Percentage of subjects who reached LDL-C target | 24 weeks | Percentage of subjects who reached LDL-C target according to Korean Society of Lipid/Arteriosclerosis's risk classification in the guidelines for the treatment of dyslipidemia (2018) at 24 weeks from baseline |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05660135/registered